Clinical Trials Directory

Trials / Completed

CompletedNCT02683850

Influence of an Omega-3 SPM Supplement on Quality of Life

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
44 (actual)
Sponsor
National University of Natural Medicine · Academic / Other
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This prospective, non-randomized, open-label study will assess if taking an Omega-3 SPM™ soft gel supplement for four weeks will increase the quality of life in adults with chronic pain.

Detailed description

One third of the America population is affected by chronic pain. The societal costs associated with chronic pain is up to $635 billion dollars annually. Prescribed pain medications may have negative side effects, or cause addictions. Having alternative treatments that can reduce inflammation and the side effects associated with chronic pain may improve the quality of life for millions. This prospective, non-randomized, open-label study will assess if taking an Omega-3 SPM™ soft gel supplement for four weeks will increase the quality of life in adults with chronic pain. SPM™ softgels are a dietary supplement intended to reduce pain and inflammation. Up to 40 men and women with chronic pain will be recruited. Outcome measures will be collected at baseline, 2 weeks, and 4 weeks with a primary endpoint of 4 weeks. The primary outcomes of this pilot study include questionnaires to assess quality of life. Exploratory outcomes assess safety and tolerability, changes in anxiety and depression as well as levels of pain, and blood markers associated with inflammation.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTOmega-3 SPM™ softgelThis four week, prospective, non-randomized, open-label study is assessing the impact on quality of life from taking an Omega-3 SPM™ softgel supplement in adults with pain symptoms at screening of 4 or higher on the PROMIS-43 Profile - Pain Intensity subscale.

Timeline

Start date
2016-01-01
Primary completion
2016-07-01
Completion
2016-07-01
First posted
2016-02-17
Last updated
2016-09-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02683850. Inclusion in this directory is not an endorsement.